SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Adaptec (ADPT) -- Ignore unavailable to you. Want to Upgrade?


To: Milk who wrote (1071)2/20/1998 5:18:00 PM
From: go_bucks  Read Replies (1) | Respond to of 5944
 
I'm not a financial guy but I don't see how these two statements
contradict each other. Adaptec is using its cash reserve to buy
Symbios.. (SKorea needs cash badly that's why ADPT is getting
a sweet deal) That's why its balance sheet is going to be
dramatically altered.

Since it's using cash to acquire, earnings will not be diluted.
and since they don't have much overlap, it's very likely (as
the management stated) that the acquisition will be
accretive to earnings the first year
.

No contradictions at all... maybe some financial whiz can give
some more insight from a pro's point of view.

Thanks

Charlie



To: Milk who wrote (1071)2/20/1998 6:16:00 PM
From: Maverick  Respond to of 5944
 
S&P Places Adaptec's Rtgs on Watch, Neg Re:Symbios Acq

NEW YORK--(BUSINESS WIRE)--Standard & Poor's CreditWire 2/20/98 --Standard
& Poor's today placed its double-'B'-plus corporate credit rating on Adaptec Inc.
[Nasdaq:ADPT - news] and its double-'B'-minus rating on the company's convertible
subordinated notes on CreditWatch with negative implications.

The CreditWatch placement follows the company's announcement that it has agreed to
acquire Symbios Inc. from Hyundai Electronics of America for $775 million. The CreditWatch
listing reflects concerns about potential acquisition integration issues.

Cash levels in excess of $700 million will be used to fund a significant portion of the $775
million cash acquisition cost; the remainder will be debt-financed. Symbios, which had 1997
revenues exceeding $600 million, will be Adaptec's largest acquisition to date. Standard &
Poor's will assess the profitability and cash flow profile of the combined operations, as well
as Adaptec's strategic and financial objectives before determining any ratings impact.

Adaptec's ratings reflect its leading position in a niche market and good cash flows, offset by
its still narrow business base and the challenges of managing its growth. Milpitas,
Calif.-based Adaptec holds the dominant market share for ''small computer systems
interface'' (SCSI) chips and adapter cards used to connect high performance peripherals to
PC-based servers and advanced desktop computers.

High gross margins, near 60% for the last two years, are derived from the company's solid
SCSI market position and the product's significant software component. Substantial R&D
expenses, close to 15% of sales, are expected to broaden the business base over time.
Operating margins in excess of 25% could decline somewhat as the company seeks to expand
its markets, and due to ongoing profitability pressure across the mass storage industry,
Standard & Poor's said. --CreditWire